$OBMP's CEO Gives Update on Progress of Prostate C
Post# of 250602
Dr. Head's presentation provided a corporate overview of OncBioMune and provided details on the company's promising pipeline of drugs in development, including ProscaVax, OncBioMune's novel vaccine in clinical trials as a new therapy for early stage prostate cancer patients.
https://youtu.be/wiOmLTWruAQ